"NEXT Oncology, Your NEXT Option™, is a Phase 1 center dedicated to providing patients with advanced cancer access to the newest cancer treatments available."

During the past decade, Next Oncology conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Next Oncology" #1 sponsor was "Mirati Therapeutics Inc." with 2 trials, followed by "Revolution Medicines, Inc." with 2 trials sponsored, "Apros Therapeutics, Inc" with 1 trials sponsored, "Ascentage Pharma Group Inc." with 1 trials sponsored and "BJ Bioscience, Inc." with 1 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Next Oncology" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Next Oncology" are "Advanced Solid Tumor" (11 trials), "Solid Tumor" (5 trials), "Solid Tumor, Adult" (5 trials), "Breast Cancer" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Next Oncology" in a lesser frequency.

Most popular intervention types in "Next Oncology" are "Drug" (31 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (3 trials), "5-fluorouracil" (1 trials), "APG-2575" (1 trials), "APR003" (1 trials) and "Albumin-Bound Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Next Oncology" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Next Oncology". undefined are not yet recruiting, 28 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Next Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Next Oncology, 34 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".